4DMedical Ltd
ASX:4DX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.41
0.79
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
4DMedical Ltd
4DMedical Ltd
Cash & Cash Equivalents
4DMedical Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
4DMedical Ltd
ASX:4DX
|
Cash & Cash Equivalents
AU$30.6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Mach7 Technologies Ltd
ASX:M7T
|
Cash & Cash Equivalents
AU$26.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
63%
|
CAGR 10-Years
47%
|
|
|
CogState Ltd
ASX:CGS
|
Cash & Cash Equivalents
$30.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
56%
|
CAGR 10-Years
41%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Cash & Cash Equivalents
AU$60.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
20%
|
CAGR 10-Years
16%
|
|
|
Medibio Ltd
ASX:MEB
|
Cash & Cash Equivalents
AU$214.1k
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
|
Medadvisor Ltd
ASX:MDR
|
Cash & Cash Equivalents
AU$15.6m
|
CAGR 3-Years
30%
|
CAGR 5-Years
29%
|
CAGR 10-Years
45%
|
|
4DMedical Ltd
Glance View
4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.
See Also
What is 4DMedical Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
30.6m
AUD
Based on the financial report for Jun 30, 2024, 4DMedical Ltd's Cash & Cash Equivalents amounts to 30.6m AUD.
What is 4DMedical Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
58%
Over the last year, the Cash & Cash Equivalents growth was -56%. The average annual Cash & Cash Equivalents growth rates for 4DMedical Ltd have been -28% over the past three years , 58% over the past five years .
You don't have any saved screeners yet
